| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |